News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Horizon Pharma, Inc. (HZNP) to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012


10/29/2012 11:20:37 AM

DEERFIELD, IL--(Marketwire - October 29, 2012) - Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that it will host a live webcast to discuss the approval and initial launch of RAYOS® on Monday, November 12, 2012 at 6:30 a.m. Eastern Time. The webcast will be hosted by Timothy P. Walbert, chairman, president and chief executive officer of Horizon Pharma and will feature presentations from leading rheumatologists Maurizio Cutolo, M.D., of the University of Genova, Frank Buttgereit, M.D., of the Charité at the University of Berlin, and Arthur Weaver, M.D., of the University of Nebraska. The live webcast and a replay may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit www.horizonpharma.com.


Contacts:
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Email Contact

Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Email Contact


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES